Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FDAPU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,481
Award facts
- Contract value 100% obligated
- $58,480.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,480.68 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML pens (2 mL units). This firm fixed-price contract, executed on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive award issued under DLA's Medical Supply Chain procurement framework. DUPIXENT (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions, making this procurement consistent with federal healthcare system pharmaceutical needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills delivery orders under this umbrella contract to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FDAPU?
SPE2DB25FDAPU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FDAPU worth?
The government has obligated $58,481 on SPE2DB25FDAPU.
Is contract SPE2DB25FDAPU an order under another contract?
Yes. SPE2DB25FDAPU is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAPU competed?
The extent of competition for SPE2DB25FDAPU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award